Cargando…
Tirzepatide Therapy in a Patient with Type 2 Diabetes Mellitus, Chylomicronemia, and Heterozygosity for Lipoprotein Lipase Deficiency
BACKGROUND/OBJECTIVE: A patient with well-controlled type 2 diabetes mellitus (T2DM) and a heterozygote for lipoprotein lipase deficiency (HeLPL) presented with chronic chylomicrons (CMs). Some patients with T2DM can develop CMs due to poor glycemic control or genetic defects that result in a decrea...
Autor principal: | Babirak, Stephan Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Clinical Endocrinology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382611/ https://www.ncbi.nlm.nih.gov/pubmed/37520761 http://dx.doi.org/10.1016/j.aace.2023.05.005 |
Ejemplares similares
-
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis
por: Vidanapathirana, Dinesha Maduri, et al.
Publicado: (2017) -
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia
por: Tanaka, Sho, et al.
Publicado: (2018) -
Tirzepatide for type 2 diabetes
por: Anderson, Sarah L, et al.
Publicado: (2023) -
Recurrent Hypertriglyceridemia-Induced Pancreatitis due to Multifactorial Chylomicronemia Syndrome in a Patient With Ketosis-Prone Diabetes Mellitus
por: Yotsapon, Thewjitcharoen, et al.
Publicado: (2022) -
A lipoprotein lipase–GPI-anchored high-density lipoprotein–binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome
por: Nimonkar, Amitabh V., et al.
Publicado: (2020)